INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 291 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,125,786 | -53.7% | 452,448 | -43.1% | 0.04% | -52.5% |
Q1 2024 | $21,884,590 | +2058.3% | 795,514 | +2292.1% | 0.08% | +1900.0% |
Q4 2023 | $1,013,975 | -65.7% | 33,256 | -54.1% | 0.00% | -71.4% |
Q2 2023 | $2,954,226 | -5.0% | 72,443 | -13.2% | 0.01% | -6.7% |
Q1 2023 | $3,109,772 | +300.8% | 83,439 | +275.2% | 0.02% | +275.0% |
Q4 2022 | $775,884 | -84.9% | 22,238 | -77.6% | 0.00% | -85.2% |
Q2 2022 | $5,144,000 | +1.8% | 99,379 | +43.0% | 0.03% | -6.9% |
Q1 2022 | $5,051,000 | -15.4% | 69,508 | +37.7% | 0.03% | -12.1% |
Q4 2021 | $5,969,000 | -80.5% | 50,485 | -77.9% | 0.03% | -83.2% |
Q3 2021 | $30,589,000 | +82.4% | 228,021 | +120.1% | 0.20% | +69.8% |
Q2 2021 | $16,774,000 | +6229.8% | 103,603 | +2028.2% | 0.12% | +5700.0% |
Q4 2020 | $265,000 | -47.6% | 4,868 | -80.9% | 0.00% | -50.0% |
Q3 2020 | $506,000 | +69.2% | 25,440 | +24.8% | 0.00% | -33.3% |
Q4 2019 | $299,000 | -44.5% | 20,382 | -38.1% | 0.01% | -60.0% |
Q2 2019 | $539,000 | – | 32,916 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |